Religare Enterprises reported a consolidated net loss of INR 46.9 crore for Q1 FY27, despite a 26% YoY revenue increase to INR 2,358 crore. The RBI rejected its demerger application, a key concern for investors.
Religare Enterprises Reports Q1 FY27 Loss, Faces RBI Demerger Rejection
Consolidated Revenue: INR 2,358 crore (up 26% YoY) Consolidated PAT: (INR 46.9 crore) Reader Takeaway: Strong operational growth in subsidiaries is overshadowed by the significant setback of the RBI rejecting the demerger plan. ## What just happened Religare Enterprises Ltd (REL) announced its Q1 FY27 financial results, revealing a consolidated net loss of INR 46.9 crore. This comes despite a 26% year-on-year increase in consolidated revenue to INR 2,358 crore. The company also confirmed that its application for a demerger has been rejected by the Reserve Bank of India (RBI). Management is currently in discussions with the RBI to understand the concerns and find a way forward. ## Why this matters The RBI's rejection of the demerger is a significant concern for shareholders, potentially impacting strategic plans for unlocking value. While subsidiaries like Care Health Insurance and the broking arm show strong growth, the demerger issue could weigh on investor sentiment and future stock performance. ## The backstory Religare Enterprises has been working on restructuring its business, including the demerger plan, to streamline operations and enhance shareholder value. The company has also seen leadership changes aimed at strengthening its foundations for future growth. Care Health Insurance is a major subsidiary, focusing on digital issuance and claims processing. ## What changes now Management is actively engaging with the RBI to address the concerns behind the demerger rejection. Investors will be closely watching for updates on this dialogue and any potential alternative strategies the company might explore. Operational growth in segments like health insurance and broking is expected to continue. ## Risks to watch The primary risk is regulatory, stemming from the RBI's stance on the demerger. Accounting standard changes (Ind AS 117) are also noted as a reason for temporary variances in consolidated results. Investors need to monitor any further communication from the RBI. ## Peer comparison Care Health Insurance reported a 37% YoY growth in Gross Written Premium (GWP) and holds a 6.7% market share in the overall insurance industry and 24% in the Standalone Health Insurance (SAHI) segment. Its solvency ratio stood at 1.58 at the end of June 2026. ## Context metrics (time-bound) - Care Health Insurance raised INR 150 crore via a rights issue in Q1 FY27 and INR 200 crore via sub-debt in August 2026. - Broking income grew 7% YoY to INR 99.5 crore, with Profit Before Tax (PBT) up 53% YoY to INR 10 crore. - Assets under custody in broking stood at INR 47,946 crore. ## What to track next Investors should track management's progress in discussions with the RBI regarding the demerger. Updates on alternative value-unlocking strategies and the continued operational performance of subsidiaries like Care Health Insurance and the broking division will also be crucial.
